Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125728501 | 12572850 | 1 | I | 20160701 | 20160712 | 20160720 | 20160720 | EXP | US-AMGEN-USACT2016090758 | AMGEN | 26.00 | YR | A | M | Y | 87.98000 | KG | 20160720 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125728501 | 12572850 | 1 | PS | carfilzomib | CARFILZOMIB | 1 | Intravenous (not otherwise specified) | 44 MG, PER CHEMO REGIM | U | 202714 | 44 | MG | INTRAVENOUS INFUSION | ||||||
| 125728501 | 12572850 | 2 | SS | CYTOXAN | CYCLOPHOSPHAMIDE | 1 | Unknown | 300 MG/M2, BID | 0 | 300 | MG/M**2 | BID | |||||||
| 125728501 | 12572850 | 3 | SS | CYTARABINE. | CYTARABINE | 1 | Unknown | 3 G/M2, Q12H | 0 | BID | |||||||||
| 125728501 | 12572850 | 4 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 40 MG, UNK | 0 | 40 | MG | ||||||||
| 125728501 | 12572850 | 5 | SS | ADRIAMYCIN | DOXORUBICIN HYDROCHLORIDE | 1 | Unknown | 50 MG/M2, UNK | 0 | 50 | MG/M**2 | ||||||||
| 125728501 | 12572850 | 6 | SS | METHOTREXATE. | METHOTREXATE | 1 | Intravenous (not otherwise specified) | 1000 MG/M2, UNK | 0 | 1000 | MG/M**2 | ||||||||
| 125728501 | 12572850 | 7 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | 2 MG, UNK | 0 | 2 | MG | ||||||||
| 125728501 | 12572850 | 8 | SS | RITUXIMAB | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 375 MG/M2, UNK | 0 | 375 | MG/M**2 | ||||||||
| 125728501 | 12572850 | 9 | C | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | 500 MG, QD | 0 | 500 | MG | QD | |||||||
| 125728501 | 12572850 | 10 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, QD, A.C (BEFORE MEALS) | 0 | 40 | MG | QD | |||||||
| 125728501 | 12572850 | 11 | C | COMPAZINE | PROCHLORPERAZINE MALEATE | 1 | Oral | 10 MG, Q6H, AS NECESSARY | 0 | 10 | MG | QID | |||||||
| 125728501 | 12572850 | 12 | C | DIFLUCAN | FLUCONAZOLE | 1 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125728501 | 12572850 | 1 | Acute lymphocytic leukaemia |
| 125728501 | 12572850 | 2 | Acute lymphocytic leukaemia |
| 125728501 | 12572850 | 3 | Acute lymphocytic leukaemia |
| 125728501 | 12572850 | 4 | Acute lymphocytic leukaemia |
| 125728501 | 12572850 | 5 | Acute lymphocytic leukaemia |
| 125728501 | 12572850 | 6 | Acute lymphocytic leukaemia |
| 125728501 | 12572850 | 7 | Acute lymphocytic leukaemia |
| 125728501 | 12572850 | 8 | Acute lymphocytic leukaemia |
| 125728501 | 12572850 | 11 | Nausea |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125728501 | 12572850 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125728501 | 12572850 | Clostridium difficile infection | |
| 125728501 | 12572850 | Diarrhoea | |
| 125728501 | 12572850 | Febrile neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |